Asuragen (United States)

Recent papers from Asuragen (United States)

1. Abstract 1121: Detection of postoperative minimal residual disease in colorectal cancer using a novel ultrasensitive whole-genome sequencing-based ctDNA testCancer Research · 2026
2. Abstract 7826: Monitoring molecular residual disease in colorectal cancer using tumor-informed ctDNA analysis.Cancer Research · 2026
3. An Exosomal mRNA Urine Test for Detection and Risk Stratification of Human Kidney Transplant RejectionKidney International Reports · 2025
4. Abstract LB393: Exosome based multiomics combined with cfDNA methylation reveals complementary signatures in blood based liquid biopsy that carry promise for minimally invasive colorectal cancer screeningCancer Research · 2024
5. Abstract 4626: A kit targeting detection of ESR1 mutations from circulating exosomal RNA and cell-free DNA supports longitudinal studies into endocrine therapy resistance in a broadly accessible RT-qPCR formatCancer Research · 2024
6. Abstract 351: Quaratusugene ozeplasmid mediated TUSC2 upregulation in EML4-ALK bearing non-small cell lung carcinoma can induce cellular apoptosisCancer Research · 2024
7. Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction2024
8. Recommendations for Interpreting and Reporting Silent Carrier and Disease-Modifying Variants in SMA Testing WorkflowsGenes · 2022
9. Calcimimetic use in US hemodialysis facilities in first 2 years after the launch of etelcalcetide: A descriptive analysis of real‐world clinical practice and outcomesHemodialysis International · 2021
10. A roadmap to better COVID-19 testing from the Coronavirus Standards Working Group2021
11. A Novel Triplet-Primed PCR Assay to Detect the Full Range of Trinucleotide CAG Repeats in the Huntingtin Gene (HTT)International Journal of Molecular Sciences · 2021
12. A Genotype-Phenotype Study of High-Resolution FMR1 Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral AssessmentsBrain Sciences · 2020
13. Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA MeasurementsJournal of Molecular Diagnostics · 2019
14. Expansions and contractions of the FMR1 CGG repeat in 5,508 transmissions of normal, intermediate, and premutation allelesAmerican Journal of Medical Genetics Part A · 2019
15. An Integrated Next-Generation Sequencing System for Analyzing DNA Mutations, Gene Fusions, and RNA Expression in Lung CancerTranslational Oncology · 2019
16. Absence of AGG Interruptions Is a Risk Factor for Full Mutation Expansion Among Israeli FMR1 Premutation CarriersFrontiers in Genetics · 2018
17. Design, Optimization, and Multisite Evaluation of a Targeted Next-Generation Sequencing Assay System for Chimeric RNAs from Gene Fusions and Exon-Skipping Events in Non–Small Cell Lung CancerJournal of Molecular Diagnostics · 2018
18. Comprehensive genotyping of the C9orf72 hexanucleotide repeat region in 2095 ALS samples from the NINDS collection using a two-mode, long-read PCR assayAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2018
19. Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid LesionsThyroid · 2017
20. Association of skewed X-chromosome inactivation with FMR1 CGG repeat length and anti-Mullerian hormone levels: a cohort studyReproductive Biology and Endocrinology · 2017